Meet the Editorial Board Member

Stefano Angioni
In: Current Drug Therapy · 2022 · vol. 17(3) , pp. 147 · doi:10.2174/157488551703220701121747 · W4283774957
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This article introduces a new member of the editorial board.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text ⓘ

The provided text lists multiple publications (including an exploratory real-world cohort study in women with multiple sclerosis and several endometriosis-focused studies and a systematic review), but it does not include the actual content of a single specific paper to summarize. One listed paper, Berlanda et al., examines how endometriosis affects obstetric outcomes after natural conception in a multicenter Italian cohort, while others address hysteroscopic metroplasty for septate uterus, interventions to improve quality of life for endometriosis patients, and laparoscopic diode-laser treatment of deep endometriosis. A major limitation is that, without the full body text for the target article, the key findings and explicit caveats cannot be accurately extracted. Relevance to endometriosis: the corpus includes multiple endometriosis papers in the provided text (e.g., Berlanda et al. on obstetric outcomes after natural conception), though the overall snippet does not specify a single paper for summarization.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,518 characters · extracted from oa-doi-fallback · click to expand
[1] Lorefice L, Fronza M, Fenu G, et al. Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study. Neurol Ther 2022; 11(1): 39-49. [http://dx.doi.org/10.1007/s40120-021-00297-6] [http://dx.doi.org/10.1007/s40120-021-00297-6] [2] Berlanda N, Alio W, Angioni S, et al. Endometriosis Treatment Italian Club (ETIC). Impact of Endometriosis on Obstetric Outcome after Natural Conception: A Multicenter Italian Study. Arch Gynecol Obstet 2022; 305(1): 149-57. [http://dx.doi.org/10.1007/s00404-021-06243-z] [http://dx.doi.org/10.1007/s00404-021-06243-z] [3] Nappi L, Falagario M, Angioni S, De Feo V, Bollino M, Sorrentino F. The Use of Hysteroscopic Metroplasty with Diode Laser to Increase Endometrial Volume in Women with Septate Uterus: Preliminary Results. Gynecol Surg 2021; 18(1) [http://dx.doi.org/10.1186/s10397-021-01093-8] [http://dx.doi.org/10.1186/s10397-021-01093-8] [4] D’Alterio MN, Saponara S, Agus M, et al. Medical and Surgical Interventions to Improve the Quality of Life for Endometriosis Patients: A Systematic Review. Gynecol Surg 2021; 18(1) [http://dx.doi.org/10.1186/s10397-021-01096-5] [http://dx.doi.org/10.1186/s10397-021-01096-5] [5] Angioni S, Nappi L, Sorrentino F, et al. Laparoscopic Treatment of Deep Endometriosis with a Diode Laser: Our Experience. Arch Gynecol Obstet 2021; 304(5): 1221-31. [http://dx.doi.org/10.1007/s00404-021-06154-z] [http://dx.doi.org/10.1007/s00404-021-06154-z] 23 1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK